One of the many aggressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst thing about this is that it is usually detected in it's late stages when it is extremely hard to make treatments.
As the symptoms of neuroendocrine colon cancer become visible only in the most advanced stages the chances of survival drops at an alarming rate. The polyps or tumors of the colon are malignant and are usually detected with distant metastases. Most recent surveys show that reports reveal that in almost all cases of neuroendocrine cancer result in death.
Though chances of neuroendocrine carcinoma in colon are extremely unlikely, if one is affected the health of the patient appears even worse than patients who suffer from adenocarcinoma.
Research shows that the end results of this form of cancer do not change with age, sex or tumor location. Though neuroendocrine colon carcinoma will depend heavily on the tumor's stage. The usual trends have revealed that people in stage 1 and 2 of cancer will generally not experience neuroendocrine colon cancer. But alternately in many cases if the tumor is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
Unfortunately, medical science has developed no adequate methods to deal with this particular cancer. A more common technique that doctors might use is immunohistochemical staining methods. this method assists doctors in dealing with the severity of the neuroendocrine colon cancer and helps to determine the most helpful medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of the tumor with a monoclonal antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.
Neuroendocrine colon carcinoma is hard to treat and a case study in which several patients stuffered from this particular disease were examined, it was noted that the average survival rate for this disease was in most cases, seven months. In the later stages these rates decrease, to as low as five months or less. Most of these cases were initially detected as carcinoids but they soon became in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not always a guaranteed treatment so surgery may not even cure the patient. so it is critical to make note of carcinoma quickly and administer the proper treatment.
As the symptoms of neuroendocrine colon cancer become visible only in the most advanced stages the chances of survival drops at an alarming rate. The polyps or tumors of the colon are malignant and are usually detected with distant metastases. Most recent surveys show that reports reveal that in almost all cases of neuroendocrine cancer result in death.
Though chances of neuroendocrine carcinoma in colon are extremely unlikely, if one is affected the health of the patient appears even worse than patients who suffer from adenocarcinoma.
Research shows that the end results of this form of cancer do not change with age, sex or tumor location. Though neuroendocrine colon carcinoma will depend heavily on the tumor's stage. The usual trends have revealed that people in stage 1 and 2 of cancer will generally not experience neuroendocrine colon cancer. But alternately in many cases if the tumor is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
Unfortunately, medical science has developed no adequate methods to deal with this particular cancer. A more common technique that doctors might use is immunohistochemical staining methods. this method assists doctors in dealing with the severity of the neuroendocrine colon cancer and helps to determine the most helpful medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of the tumor with a monoclonal antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.
Neuroendocrine colon carcinoma is hard to treat and a case study in which several patients stuffered from this particular disease were examined, it was noted that the average survival rate for this disease was in most cases, seven months. In the later stages these rates decrease, to as low as five months or less. Most of these cases were initially detected as carcinoids but they soon became in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not always a guaranteed treatment so surgery may not even cure the patient. so it is critical to make note of carcinoma quickly and administer the proper treatment.
About the Author:
Today is the perfect time to find out more about Colon Hydro Therapie. Join us Colon Hydrotherapy School.
No comments:
Post a Comment